Safety

HHS pays $122.7M for manufacture of anthrax vaccine

Emergency Management Alert, May 10, 2005

The federal Department of Health and Human Services (HHS) recently awarded a $122.7 million contract to a Michigan company to produce five million doses of an anthrax vaccine.

BioPort Corporation, which is based in Lansing, will manufacture Anthrax Vaccine Adsorbed for the nation's Strategic National Stockpile. It will be available in the event of a bioterrorism anthrax attack.

The supply of the anthrax vaccine is paid for under Project BioShield, a federal program intended to accelerate the development, purchase, and availability of medical weapons against biological, chemical, radiological, and nuclear threats.

    Hospital Safety Center
  • Hospital Safety Center

    Improve compliance with hospital safety standards from The Joint Commission, OSHA, and other regulators with this...

  • Healthcare Life Safety Compliance

    Learn Life Safety Code tips and interpretations for healthcare facilities with this in-depth monthly resource.

  • Hospital Safety Connection

    Stay on top of hospital safety requirements and best practices with our free, fast-paced weekly update.

  • Administering Your OSHA Program

    This course will help an employee new to the role of OSHA safety officer. It gives an overview of OSHA requirements and...

  • Medical OSHA Manual Combo

    Get into compliance with Quality America's OSHA Safety Program Manual and stay in compliance with OSHA Watch Newsletter...

Most Popular

Related Articles